Royal Orchid Hotels Q1FY27: EBITDA up 39%, PAT hits ₹6.8 crore
Royal Orchid Hotels Q1FY27 results show strong top-line growth with consolidated revenue rising 38.5% to ₹114.70 crore and EBITDA jumping 39.1% to ₹32.93 crore. However, PAT fell 39.3% to ₹6.79 crore due to IndAS impacts and a ₹2.5 crore GST input loss. Management clarified that non-IndAS PAT was ₹9.8 crore and highlighted expansion in JLO hotel ADRs and occupancy.

*this image is generated using AI for illustrative purposes only.
Royal Orchid Hotels Limited reported a consolidated total income of ₹114.70 crore for the quarter ended June 30, 2026 (Q1FY27), marking a 38.5% year-on-year increase from ₹82.80 crore in Q1FY26. The growth was driven by strategic portfolio expansion, with the company opening five new hotels comprising 237 keys in key markets including Hyderabad, Tirupati, Ahmedabad, and Rishikesh during the quarter. Consolidated EBITDA rose 39.1% to ₹32.93 crore from ₹23.67 crore in the corresponding period last year, reflecting improved operational efficiencies across its 123+ hotel portfolio. Cash profit, excluding the impact of the Iconiqa brand, stood at ₹16.9 crore.
Despite the top-line surge, consolidated profit after tax (PAT) declined to ₹6.79 crore from ₹11.19 crore in Q1FY26. This reduction was primarily attributed to the adoption of IND-AS accounting standards, which led to a notional increase in depreciation and finance costs of ₹20.21 crore, resulting in a ₹3.40 crore reduction in PAT. On a standalone basis, total income grew modestly by 10.4% to ₹53.51 crore from ₹48.46 crore, while standalone EBITDA dipped slightly to ₹11.03 crore from ₹11.88 crore. Standalone PAT decreased to ₹2.82 crore from ₹3.62 crore in the prior year quarter.
| Metric | Q1 FY27 (Consolidated) | Q1 FY26 (Consolidated) | YoY Change |
|---|---|---|---|
| Total Income | ₹114.70 crore | ₹82.80 crore | +38.5% |
| EBITDA | ₹32.93 crore | ₹23.67 crore | +39.1% |
| PAT | ₹6.79 crore | ₹11.19 crore | -39.3% |
| EPS | ₹2.34 | ₹3.99 | -41.4% |
The Board of Directors approved these unaudited standalone and consolidated financial results on August 11, 2026, alongside a recommendation for a final dividend of ₹2.5 per share for FY25-26. The record date for determining shareholder entitlement is fixed at August 28, 2026, subject to approval at the 40th Annual General Meeting (AGM) scheduled for September 26, 2026. The dividend payment is expected on or after the AGM date. Statutory auditors issued a limited review report on the results, complying with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Earnings Call Insights
During the post-earnings conference call held on August 14, 2026, management provided further context on the financial performance. Chairman and Managing Director Chander K. Baljee noted that consolidated revenue rose 36% year-on-year to approximately ₹107 crore, with total revenue standing higher at ₹115 crore. He highlighted that EBITDA margin expanded modestly to approximately 30.7% from 30%. However, net profit declined to around ₹6.4 crore versus ₹10.9 crore last year, driven by higher financial costs, depreciation including IndAS impacts, and the ongoing ramp-up of newer properties, particularly larger-leased assets.
Chief Financial Officer Amit Jaiswal clarified that the growth from the five new hotels (237 keys) was negligible as they operate under managed and franchisee models, contributing only management fees. The major revenue contribution came from Joint Leased Owned (JLO) hotels. JLO hotels recorded an occupancy of 70% and an Average Daily Rate (ADR) of ₹6,233, up from ₹5,488 in the previous year. Managed hotels saw an occupancy of 60.8% and an ADR of ₹4,300, up from ₹4,031.
Key Operational Challenges
Management identified specific headwinds affecting profitability:
- GST Input Loss: A change in GST regulations resulted in an input loss of ₹2.5 crore for the quarter. Previously, the company could offset GST output against input credit; under the new regime, with output tax at 5% for rates below ₹7,500, input tax credit is not allowed, leading to a write-off.
- Iconiqa Ramp-up: The Iconiqa brand, which became operational in November 2025, is still in its gestation period. Occupancy fluctuated between 79% in April, 60% in May, and 70% in June, impacted by global flight cancellations and seasonal business hotel trends. Management indicated that Iconiqa would break even on an annualized top line of ₹85 crore (excluding IndAS), with 50-65% of revenue above this threshold flowing to the bottom line.
- Employee Costs: Standalone employee costs have risen to 23% of revenue from 19-20% levels over the last eight quarters, attributed to a new wage code, annual increments, and strengthening of the management team. Management expects this to stabilize within a year as revenues increase.
Strategic Expansion and Governance
Royal Orchid Hotels continues to accelerate its asset-light growth strategy, supported by a robust pipeline of over 50 upcoming properties representing more than 3,600 keys. The company remains on track towards its Vision 2030 target of 345 hotels and 22,000 keys. Management emphasized its focus on high-demand business corridors, pilgrimage destinations, and metro gateway locations to sustain long-term value creation. The group operates through a segmented brand ecosystem including Royal Orchid Hotels, Regenta Hotels, and the upscale brand ICONIQA.
In governance developments, the Board approved the re-appointment of Venkata Ramana Murthy Pinisetty as an Independent Director for a second term from October 9, 2026, to October 8, 2028, pending shareholder approval. Additionally, Padmini V. Krupanidhi, Company Secretary & Compliance Officer, was appointed as the Nodal Officer for coordinating with the Investor Education and Protection Fund (IEPF) Authority, ensuring dedicated oversight for investor grievance redressal pursuant to Rule 7(2A) of the IEPF Authority Rules, 2016.
What the Numbers Show
The divergence between strong revenue/EBITDA growth and declining PAT highlights the significant impact of accounting standard changes and regulatory shifts on reported profitability. While operational performance improved substantially with nearly 40% growth in EBITDA, the non-cash impact of increased depreciation under IND-AS suppressed net profits. Furthermore, the ₹2.5 crore GST input loss represents a tangible operational drag not present in prior periods. Investors should focus on the underlying operational leverage and portfolio expansion metrics, which indicate robust demand recovery and successful execution of the asset-light strategy, rather than the one-time accounting adjustment and regulatory cost affecting PAT. The company’s current ROCE stands at 17-18%, with management targeting 20%+ once Iconiqa stabilizes.
Historical Stock Returns for Royal Orchid Hotels
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.02% | -1.52% | -4.86% | -13.95% | -46.04% | +305.91% |
How will the sustained GST input tax credit loss impact Royal Orchid's long-term EBITDA margins, and are there strategic pricing adjustments planned to offset this regulatory headwind?
Given the Iconiqa brand's current gestation period, what specific milestones must be achieved in the next two quarters to validate management's claim of reaching breakeven on an annualized top line of ₹85 crore?
With employee costs rising to 23% of revenue, what operational efficiencies or automation strategies is the company deploying to bring this metric back to the historical 19-20% range within the projected one-year timeline?


































